首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   70958篇
  免费   2748篇
  国内免费   3184篇
耳鼻咽喉   403篇
儿科学   1580篇
妇产科学   1736篇
基础医学   5089篇
口腔科学   2089篇
临床医学   6706篇
内科学   10012篇
皮肤病学   491篇
神经病学   1589篇
特种医学   3798篇
外国民族医学   1篇
外科学   4656篇
综合类   15841篇
一般理论   8篇
预防医学   8141篇
眼科学   1272篇
药学   5084篇
  5篇
中国医学   5446篇
肿瘤学   2943篇
  2023年   212篇
  2022年   348篇
  2021年   389篇
  2020年   385篇
  2019年   247篇
  2018年   371篇
  2017年   339篇
  2016年   391篇
  2015年   437篇
  2014年   678篇
  2013年   965篇
  2012年   1600篇
  2011年   4624篇
  2010年   2783篇
  2009年   1907篇
  2008年   2375篇
  2007年   2133篇
  2006年   2222篇
  2005年   3307篇
  2004年   8148篇
  2003年   7382篇
  2002年   5813篇
  2001年   4648篇
  2000年   2871篇
  1999年   3458篇
  1998年   2421篇
  1997年   2154篇
  1996年   1421篇
  1995年   1256篇
  1994年   1254篇
  1993年   1992篇
  1992年   1670篇
  1991年   1403篇
  1990年   1042篇
  1989年   880篇
  1988年   683篇
  1987年   568篇
  1986年   564篇
  1985年   290篇
  1984年   161篇
  1983年   95篇
  1982年   76篇
  1981年   70篇
  1980年   56篇
  1979年   76篇
  1978年   51篇
  1977年   63篇
  1976年   43篇
  1975年   66篇
  1974年   50篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
The specialty of emergency medicine in Australasia is coming of age. As part of this maturation there is a need for high‐quality evidence to inform practice. This article describes the development of the New Zealand Emergency Medicine Network, a collaboration of committed emergency care researchers who share the vision that New Zealand/Aotearoa will have a world‐leading, patient‐centred emergency care research network, which will improve emergency care for all, so that people coming to any ED in the country will have access to the same world‐class emergency care.  相似文献   
2.
3.
4.
目的:探讨福赛类杆菌与人类唾液富脯蛋白相互作用的蛋白分子。方法:Western—blot方法。将人工合成唾液富脯蛋白用生物素标记,福赛类杆菌全菌蛋白凝胶电泳,半干转移至纤维膜上,观察二者的相互作用。结果:富脯蛋白能与分子量为85KD、65KD、60KD、以及49KD的福赛类杆菌蛋白发生结合。结论:福赛类杆菌存在与人类唾液富脯蛋白相互结合的粘附素。  相似文献   
5.
Objective Ligustrazine, also named as tetramethylpyrazine, is a compound purified from Ligusticum chuanxiong hort and has ever been testified to be a calcium antagonist. The present investigation was to determine the antinoci-ceptive effect of ligustrazine and, if any, the peripheral ionic mechanism involved. Methods Paw withdrawal Latency ( PWL) to noxious heating was measured in vivo and whole-cell patch recording was performed on small dorsal root ganglion (DRG) neurons. Results Intraplantar injection of ligustrazine (0.5 mg in 25μl) significantly prolonged the withdrawal latency of ipsilateral hindpaw to noxious heating in the rat. Ligustrazine not only reversibly inhibited high-voltage gated calcium current of dorsal root ganglion (DRG) neuron in dose-dependent manner with IC50 of 1.89 mmol/L, but also decreased tetrodotoxin (TTX) -resistant sodium current in relatively selective and dose-dependent manner with IC50 of 2.49 mmol/L. Conclusion The results suggested that ligustrazine could elevate the threshold of thermal nociception through inhibiting the high-voltage gated calcium current and TTX-resistant sodium current of DRG neuron in the rat.  相似文献   
6.
Background: Large randomized trials show that in appropriately selected patients with left ventricular dysfunction, implantable cardioverter-defibrillators (ICDs) can improve overall survival at 2–5 years. Since direct implementation of the criteria used in the MADIT II and SCD-HeFT will lead to a marked rise in ICD implants, there is a growing fear that increased use of ICDs may cause a dramatic burden to health care systems. The ICD has traditionally been seen as an expensive form of treatment, which is difficult to accept at the first look. This is mainly due to the nonlinear character of the ICD investment, characterized by high initial expenditure, followed by a deferred pay-off in terms of clinical benefits. Cost-effectiveness analysis may help provide a different perspective on the problem of ICD cost, as may estimation of the daily cost of ICD treatment, assuming a time horizon of 5–7 years—a particularly interesting subject for further registry studies.
Methods and Results: Based on real expenditure data from 2002 to 2005, as recorded in the Search-MI Registry-Italian Sub-study of patients implanted on MADIT II indications, we estimated the daily costs associated with the device and leads. Over a 5–7 year time horizon, the average daily cost was estimated to be €4.60–€6.70. Translation of these figures into U.S. market conditions suggests a daily cost of around $7.90–$11.40.
Conclusions: These findings appear useful to help evaluate the affordability of ICD in comparison with other therapeutic options in a context of limited available economic resources.  相似文献   
7.
8.
9.
10.
目的:探讨缺血再灌注脑组织病理形态及丙二醛含量变化的关系.方法:阻断双侧颈总动脉和椎动脉结合低血压法复制兔脑完全性缺血再灌注模型,观察心脉龙对脑组织病理形态变化及脂质过氧化的影响.结果:心脉龙能抑制膜脂质过氧化作用,且缺血再灌注脑组织丙二醛含量变化与其病理形态改变具有一致性.结论:动态观察血液丙二醛,可作为评价脑缺血性疾病治疗和预后的检测指标.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号